Soluble antigens in plasma allow mismatched transfusion without hemolysis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Transfusion

• Publication date

  2018-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/trf.14510PMID 29392728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reactions

  2022cited by this paper
• Incompatible type A plasma transfusion in patients requiring massive transfusion protocol: Outcomes of an Eastern Association for the Surgery of Trauma multicenter study

  2017cited by this paper
• Measurement of haemolysis markers following transfusion of uncrossmatched, low‐titre, group O+ whole blood in civilian trauma patients: initial experience at a level 1 trauma centre

  2017cited by this paper
• Safety of the use of group A plasma in trauma: the STAT study

  2017cited by this paper
• The state of the science of whole blood: lessons learned at Mayo Clinic

  2016cited by this paper
• Low Titer Group O Whole Blood in Emergency Situations

  2014cited by this paper
• Is group A thawed plasma suitable as the first option for emergency release transfusion? (CME)

  2014cited by this paper
• The Significance of Erythrocyte Antigen Site Density

  2013cited by this paper
• Emergency use of prethawed Group A plasma in trauma patients

  2013cited by this paper
• ABO antibody titers are not predictive of hemolytic reactions due to plasma‐incompatible platelet transfusions

  2012cited by this paper
• Challenging dogma: group A donors as “universal plasma” donors in massive transfusion protocols

  2011cited by this paper
• ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.

  2010cited by this paper
• Probiotic‐associated high‐titer anti‐B in a group A platelet donor as a cause of severe hemolytic transfusion reactions

  2009cited by this paper
• Problems associated with passively transfused blood group alloantibodies.

  1998cited by this paper
• Antibodies to histo‐blood group substances A and B: agglutination titers, Ig class, and IgG subclasses in healthy persons of different age categories

  1991cited by this paper
• Quantitative flow cytometric analysis of ABO red cell antigens.

  1991cited by this paper
• The significance of erythrocyte antigen site density. II. Hemolysis.

  1971cited by this paper
• A DISTRIBUTION-FREE k-SAMPLE TEST AGAINST ORDERED ALTERNATIVES

  1954cited by this paper

• In-vitro Dilution of Human Plasma to Reduce ABO Antibody Titer Levels While Preserving Coagulation Factors

  2024cites this paper
• Current state of whole blood transfusion for civilian trauma resuscitation

  2020cites this paper
• Group A emergency-release plasma in trauma patients requiring massive transfusion

  2020cites this paper
• Immunologic risks of whole blood: ABO compatibility, D alloimmunization, and transfusion‐related acute lung injury

  2019cites this paper
• Reducing AB plasma utilisation through the AB plasma appropriateness index

  2019cites this paper
• Safety of the use of group A plasma in trauma: the STAT study

  2017cites this paper